Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David S. Poch
Case Report: A Patient With Pulmonary Arterial Hypertension Transitioning From a PDE-5 Inhibitor to Riociguat
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Related publications
Pulmonary Arterial Hypertension in a Patient Treated With Dasatinib: A Case Report
Journal of Medical Case Reports
Medicine
RESPITE: Switching to Riociguat in Pulmonary Arterial Hypertension Patients With Inadequate Response to Phosphodiesterase-5 Inhibitors
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Pulmonary Arterial Hypertension in a Patient With Multiple Sclerosis Treated With Interferon Beta: A Case Report
Journal of Neurology and Neuroscience
A Focus on Riociguat in the Treatment of Pulmonary Arterial Hypertension
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Transitioning the Pediatric Pulmonary Hypertension Patient
Advances in Pulmonary Hypertension
Initial Riociguat Monotherapy and Transition From Sildenafil to Riociguat in Patients With Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular–Pulmonary Arterial Coupling
Lung
Pulmonary
Respiratory Medicine
Treatment Patterns Among Patients Prescribed Pde-5 Inhibitor Monotherapy for Pulmonary Hypertension
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Medical Council
Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center
Cardiology and Therapy
